Novel Test Predicts Breast Cancer Recurrence and Radiation Therapy Benefit LAGUNA HILLS, Calif. – March 12, 2026 – A new multi-omic test, AidaBreast™, developed by Prelude Corporation (PreludeDx®), shows promise …
Tag: